Bristol-Myers Squibb Company (NYSE:BMY) 345 Park Avenue New York, NY 10154 Phone: (212) 546-4000 Fax: (212) 546-4020 http://www.bms.com
Bristol-Myers Squibb Company was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business started in 1887. In 1989, Bristol-Myers Company changed its name to Bristol-Myers Squibb Company as a result of a merger. It is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life by providing the highest quality pharmaceutical and related health care products. The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products. The Company reports financial and operating information in two segments, Pharmaceuticals and Nutritionals. The Nutritionals segment is operated through the Company's subsidiary Mead Johnson Nutrition Company. The Nutritionals segment, through Mead Johnson, manufactures, markets, distributes and sells infant formulas and other nutritional products, including the entire line of ENFAMIL products. The ENFAMIL LIPIL product is the first infant formula in the U.S. to contain the nutrients docosahexaenoic acid and arachidonic acid. The Pharmaceuticals segment competes with other worldwide research-based drug companies, smaller research companies and generic drug manufacturers. These products are sold worldwide, mainly to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The Pharmaceuticals segment is comprised of the global pharmaceutical and international consumer medicines businesses. The products comprises of cardiovascular; virology, including human immunodeficiency virus infection; oncology; affective and other disorders; and immunoscience. The Company promotes its products in medical journals and directly to health care providers such as doctors, nurse practitioners, physician assistants, pharmacists, technologists, hospitals, Pharmacy Benefit Managers, Managed Care Organizations and government agencies. The markets in which the Company competes are generally broad-based and highly competitive. The Company is subject to global regulation by regional, country, state and local agencies.
BUYandHOLD does not offer or provide any investment advice
or opinion regarding the nature, potential, value, suitability
or profitability of any particular security, portfolio of
securities, transaction or investment strategy. Any investment
decisions you make will be based solely on your evaluation
of your financial circumstances, investment objectives, risk
tolerance, and liquidity needs. The security and information
listed above and is being provided for informational purposes
only and should not be regarded as an offer to sell or as
a solicitation of an offer to buy and past performance is
no guarantee of future results.
The BUYandHOLD
website contains links to third-party websites on the Internet.
BUYandHOLD provides these links to these websites only as
a convenience to users of the website. Links on the BUYandHOLD
website are not endorsements by BUYandHOLD or Freedom Investments,
implied or express, of the linked sites or any products, services
or links in such sites; and no information in such sites has
been endorsed or approved by BUYandHOLD. Linked sites are
not under the control of BUYandHOLD or Freedom Investments,
and we are not responsible for the contents of any linked
site or any link contained in a linked site. No information
contained in the BUYandHOLD website or accessed through any
linked site, or any link contained in a linked site, constitutes
a recommendation by BUYandHOLD or Freedom Investments to buy,
sell or hold any security, financial product or instrument.
Information accessed through linked sites is not, nor should
be construed as, an offer or a solicitation of an offer, to
buy or sell securities by BUYandHOLD or Freedom Investments.
BUYandHOLD does not offer or provide any investment advice
or opinion regarding the nature, potential, value, suitability
or profitability of any particular security, portfolio of
securities, transaction or investment strategy, and any investment
decisions you make will be based solely on your evaluation
of your financial circumstances, investment objectives, risk
tolerance, and liquidity needs.
